Skip to main content

Table 1 Baseline characteristics of stroke patients in the two groups

From: Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke

 

With pre-existing statin use (n= 43)

Without pre-existing statin use (n= 129)

Pvalue

Age (years) (mean ± SEM)

67.5 ± 1.4

64.0 ± 1.2

0.43

Male (%)

69.8

60.6

0.41

Hypertension (%)

83.7

74.2

0.39

Diabetes mellitus (%)

58.1

31.8

0.01

Coronary artery diseases (%)

7.0

3.0

0.37

Intracranial atherosclerosis (%)

30.2

24.2

0.64

Stroke subtype

   

   Small-vessel disease

51.3

60.0

0.42

   Large-vessel disease

48.7

40.0

 

Median NIHSS (IQR) scores on admission

4 (2.0-7.0)

5 (2.5-7.75)

0.03

  1. IQR, inter-quartile range; NIHSS, National Institutes of Health Stroke Scale; SEM, standard error of the mean.